Patient factors associated with receiving reversal therapy in oral anticoagulant-related intracerebral hemorrhage.
Journal Information
Full Title: Acta Neurol Scand
Abbreviation: Acta Neurol Scand
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST TAH, TU, and JP have no disclosures. BN has received honoraria for serving at data monitoring committees in the SOCRATES, THALES (AstraZeneca) and NAVIGATE‐ESUS trials (Bayer)."
Funding Disclosure
Evidence found in paper:
"FUNDING INFORMATION This study was funded by grants from “Sparbanksstiftelsen Färs & Frosta”, “STROKE‐Riksförbundet” and ALF‐grant from Region Skåne."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025